XT
TXG icon

XTX Topco’s 10x Genomics TXG Stock Holding History

XTX Topco’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81,070
Closed -$948K – 3817
2025
Q3 		$948K Buy
81,070
+23,555
+41% +$307K 0.05% 615
2025
Q2 		$666K Buy
57,515
+9,596
+20% +$87.5K 0.03% 912
2025
Q1 		$418K Sell
47,919
-4,869
-9% -$61.4K 0.02% 1155
2024
Q4 		$758K Buy
52,788
+7,780
+17% +$123K 0.06% 457
2024
Q3 		$1.02M Buy
45,008
+31,844
+242% +$658K 0.07% 419
2024
Q2 		$256K Sell
13,164
-9,185
-41% -$241K 0.02% 1065
2024
Q1 		$839K Buy
+22,349
New +$982K 0.11% 224
2023
Q4 		– Sell
-19,294
Closed -$796K – 2169
2023
Q3 		$796K Buy
19,294
+14,233
+281% +$740K 0.14% 177
2023
Q2 		$283K Buy
+5,061
New +$274K 0.05% 761
2022
Q1 		– Sell
-1,378
Closed -$205K – 959
2021
Q4 		$205K Buy
+1,378
New +$211K 0.12% 370
2021
Q3 		– Sell
-1,462
Closed -$286K – 1071
2021
Q2 		$286K Buy
+1,462
New +$265K 0.1% 385

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's TXG Position: Q4 2025 in Review

XTX Topco sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 81,070 shares — an estimated $948K sold.

XTX Topco first reported a position in TXG in Q2 2021 and held it in 11 quarters. The position peaked at $1.02M in Q3 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • XTX Topco reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 81,070 10x Genomics shares in Q4 2025, an estimated $948K.
  • XTX Topco first reported a position in 10x Genomics in Q2 2021 and held it in 11 quarters.
  • XTX Topco's 10x Genomics position peaked at $1.02M in Q3 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.